# France Extracorporeal Membrane Oxygenation Machine Market > France Extracorporeal Membrane Oxygenation Machine Market Research Report: Size, Share, Trend Analysis By Applications (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End Users (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO) andBy Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.74% - **2024:** $ 83.86 Million - **2025:** $ 88.67 Million - **2035:** $ 154.99 Million - **Key Players:** Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US) **Report ID:** MRFR/MED/49073-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/france-extracorporeal-membrane-oxygenation-machine-market-50830 --- ## Market Summary ## **France Extracorporeal Membrane Oxygenation Machine Market Overview** As per MRFR analysis, the France Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 66 (USD Million) in 2023. The France Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 69.75(USD Million) in 2024 to 131.25 (USD Million) by 2035. The France Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 5.916% during the forecast period (2025 - 2035). ### **Key France Extracorporeal Membrane Oxygenation Machine Market Trends Highlighted** The France Extracorporeal Membrane Oxygenation (ECMO) machine market is experiencing significant expansion driven by several key factors. The increasing incidence of respiratory diseases and cardiac conditions in the country has heightened demand for advanced life-support technologies. The French healthcare system has been investing heavily in developing and modernizing critical care facilities, which directly influences the adoption of ECMO systems. Moreover, an aging population in France is contributing to the rising need for innovative treatment options that can support patients with severe illnesses, positioning ECMO machines as essential medical equipment in hospitals. In recent years, there have been significant trends towards technological advancements in ECMO machines, with manufacturers emphasising the development of devices that are more compact, user-friendly, and efficient. As hospitals endeavour to enhance patient outcomes, the integration of remote monitoring functionalities and telemedicine capabilities has become increasingly critical. Furthermore, the number of healthcare personnel participating in training programs regarding the efficient operation of ECMO machines is on the rise, which is contributing to the development of confidence and proficiency in the management of intricate cases. The ECMO market in France offers a plethora of opportunities for exploration, particularly as the importance of early intervention in critical patient care becomes more widely recognised. The development of more personalised ECMO systems that are tailored to specific health requirements can be facilitated by collaborations between medical institutions and manufacturers. Moreover, the implementation of more innovative solutions in clinical practice may be facilitated by the increase in public and government support for healthcare technology innovation, which in turn can increase funding for ECMO research and development in France. This collaborative endeavour in the healthcare sector has established France as a critical participant in the advancement of ECMO technologies, thereby enhancing the outcomes of patients with severe cardiac and respiratory conditions. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **France Extracorporeal Membrane Oxygenation Machine Market Drivers** ### **Increasing Prevalence of Respiratory and Cardiac Diseases** In France, the rise in respiratory and cardiac diseases is significantly boosting the France Extracorporeal Membrane Oxygenation Machine Market Industry. According to the French Ministry of Health, chronic obstructive pulmonary disease (COPD) affects approximately 3.5 million people in France, and the incidence of heart disease is steadily increasing, projected to reach 25% of the population by 2030. This rise in disease prevalence stimulates the demand for advanced medical technologies, including extracorporeal membrane oxygenation machines, which are essential for patients requiring intensive cardiac and respiratory support. Leading medical institutions such as Assistance Publique - Hpitaux de Paris are investing heavily in these technologies to enhance patient outcomes, resulting in a robust growth trajectory for the market in France. ### **Technological Advancements in ECMO Devices** The France Extracorporeal Membrane Oxygenation Machine Market Industry is experiencing growth due to rapid technological advancements in ECMO devices. Notably, the French healthcare sector has embraced innovations such as portable ECMO machines that are more effective and easier to deploy in emergency settings. For instance, France's national health agency has reported a 15% increase in ECMO device usage within emergency settings since the introduction of these advanced models. Companies like Sorin Group, a leader in medical devices, are at the forefront of this technological development, propelling the market forward through enhanced product offerings that improve patient care in critical situations. ### **Growing Focus on Research and Development** An increasing focus on Research and Development (R&D) in the healthcare sector, particularly in critical care, is driving the France Extracorporeal Membrane Oxygenation Machine Market Industry. The French government has prioritized R&D funding, allocating around 3 billion euros annually to support medical innovations. This governmental support has led to an array of clinical trials focused on ECMO technology, with studies indicating that innovative solutions could enhance survival rates by up to 20% in severely ill patients. Institutions like the French National Institute of Health and Medical Research (INSERM) are pivotal in driving this forward, demonstrating strong collaboration between public and private sectors to enhance the capabilities of extracorporeal membrane oxygenation machines. ## **France Extracorporeal Membrane Oxygenation Machine Market Segment Insights** ### **Extracorporeal Membrane Oxygenation Machine Market Application Insights** The Application segment of the France Extracorporeal Membrane Oxygenation Machine Market plays a pivotal role in the overall healthcare system, particularly in critical care and advanced medical treatments. This segment is primarily categorized into three major areas Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass. Each segment addresses specific clinical needs and highlights the technological advancements in medical equipment. Cardiac Support is essential for managing severe cardiac conditions, offering vital assistance during surgeries and recovery phases for patients experiencing heart failure or undergoing complex cardiac procedures. This area has seen considerable innovation, driven by the increasing prevalence of cardiovascular diseases in France, thereby underscoring its significance in improving patient outcomes. Similarly, Respiratory Support is another critical component of this market segment, designed to address patients with severe respiratory distress and conditions such as Acute Respiratory Distress Syndrome (ARDS). Given the rise in pulmonary diseases, particularly in the aging population of France, the demand for effective ventilatory support systems is significant. The focus on enhancing patient care through these devices reflects ongoing advancements in medical technology, which are crucial for maintaining adequate oxygenation during critical moments. Cardiopulmonary Bypass stands out as a cornerstone of cardiac surgeries, facilitating procedures by providing a bloodless field and allowing surgical teams to operate on the heart without interruption. This segment underscores the importance of extracorporeal membrane oxygenation machines in highly specialized surgical environments, showcasing their capability to improve success rates during heart surgeries. The significance of these areas within the Application segment emphasizes not only their vital role in enhancing patient survival rates but also their contribution towards the overall advancement of the France Extracorporeal Membrane Oxygenation Machine Market. As healthcare continues to evolve, these applications will remain integral to addressing the needs of critically ill patients, thereby reinforcing their value in the medical industry. The ongoing need for improved healthcare solutions in France ensures that this segment remains robust, indicating a future of sustained growth and development driven by technological innovations and increased patient care demands. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Extracorporeal Membrane Oxygenation Machine Market End User Insights** The End User segment of the France Extracorporeal Membrane Oxygenation Machine Market is pivotal for understanding the application and demand dynamics of these critical medical devices. Hospitals represent a significant share of usage due to their advanced capacity for critical care and complex treatments that require Extracorporeal Membrane Oxygenation (ECMO). Their infrastructure is equipped with skilled personnel who can effectively operate and maintain sophisticated machinery, underlining their dominance in the market. Ambulatory Surgical Centers are gaining traction, focusing on outpatient procedures where ECMO technology can enhance patient outcomes significantly, reflecting a growing trend towards decentralized healthcare. Home Care Settings are emerging as a viable end user, driven by the push for patient-centric care models that facilitate recovery in familiar environments, thereby reducing healthcare costs in the long run. This diversification among end users is influenced by evolving patient care protocols and the increasing prevalence of respiratory and cardiac diseases in France. Each segment presents unique opportunities while hospitals continue to lead innovation and technology integration, ambulatory centers and home care settings highlight a shifting focus towards accessibility and patient comfort within the healthcare landscape. ### **Extracorporeal Membrane Oxygenation Machine Market Product Type Insights** The France Extracorporeal Membrane Oxygenation Machine Market is categorized into various product types, each playing a crucial role in providing life-saving support in critical care. Among these, Venoarterial ECMO is prominent as it is primarily utilized for patients requiring both cardiac and respiratory support, illustrating its significance in treating conditions such as cardiac arrest and severe cardiac failure. Venovenous ECMO, on the other hand, specializes in respiratory support, making it vital for patients suffering from severe lung conditions like Acute Respiratory Distress Syndrome (ARDS). This product type is crucial in hospitals across France, especially in intensive care units where quick intervention can drastically enhance patient outcomes. Arteriovenous ECMO, while less common, is important for specific applications, particularly in renal support. The segment distribution reflects preferences in treatment protocols and advancements in medical technology, shaping the overall landscape of the France Extracorporeal Membrane Oxygenation Machine Market. As the country continually enhances its healthcare infrastructure and technology, these product types are poised to adapt and grow, addressing the evolving needs of patient care in critical situations. ### **Extracorporeal Membrane Oxygenation Machine Market Component Insights** The Component segment of the France Extracorporeal Membrane Oxygenation Machine Market plays a vital role in enhancing the efficacy and efficiency of these life-support devices. Within this segment, the Membrane Oxygenator is critical as it facilitates gas exchange, essentially supporting patients with severe respiratory or cardiac failure. This technology is pivotal for patient survival and recovery, making it a dominant force within the market. Blood Pumps are equally significant, providing continuous blood flow while maintaining the necessary pressure and flow rate, thus ensuring that organs receive the needed blood supply during complex medical procedures. Additionally, Heat Exchangers, which regulate temperature fluctuations during the process, contribute to creating optimal conditions for patient care. The importance of these components underlines their necessity in critical care environments, adapting to the demands of healthcare systems in France. These components not only enhance the performance of Extracorporeal Membrane Oxygenation Machines but also reflect the ongoing advancements in medical technology that drive improvements in patient outcomes and care standards across the nation. ## **France Extracorporeal Membrane Oxygenation Machine Market Key Players and Competitive Insights** The France Extracorporeal Membrane Oxygenation Machine Market reflects a dynamic landscape characterized by the competition among several key players. This market segment has gained significant traction in recent years due to the increasing prevalence of respiratory and cardiac diseases that necessitate advanced therapeutic solutions. Notably, the market is heavily influenced by technological advancements and innovations aimed at enhancing patient outcomes. The competitive insights reveal a convergence of quality, efficacy, and regulatory compliance as fundamental pillars driving the strategies of companies operating in this domain. Furthermore, the competitive atmosphere is marked by ongoing research and development initiatives, strategic partnerships, and market expansion efforts that collectively shape the directional flow of market dynamics. Maquet holds a prominent position within the France Extracorporeal Membrane Oxygenation Machine Market, attributed largely to its extensive portfolio of advanced medical technologies that cater specifically to critical care settings. Known for its innovative solutions, Maquet is recognized for delivering high-quality ECMO machines that are tailored to meet the diverse needs of healthcare providers in France. The company boasts a strong market presence, underpinned by a commitment to enhancing patient care through sophisticated engineering and user-friendly designs. Maquet's strengths lie in their established reputation for reliability and performance, bolstered by a comprehensive after-sales service that ensures operational continuity for healthcare institutions. This focus on customer support has fostered long-term relationships with key stakeholders in the French healthcare system, further solidifying Maquet's position in the market. LivaNova is another significant player within the France Extracorporeal Membrane Oxygenation Machine Market, well-regarded for its cutting-edge products and innovative therapies aimed at enhancing life quality for patients with critical conditions. The company's strong portfolio includes a range of ECMO systems that integrate advanced technology for improved efficiency and user experience. LivaNova's market presence in France is supported by strategic ventures and collaborations aimed at expanding its footprint in the critical care industry. Its strength lies in the critical partnerships it has formed with local hospitals and healthcare institutions, allowing for better access to its solutions. In recent years, LivaNova has engaged in mergers and acquisitions to broaden its technological capabilities and market reach, reinforcing its commitment to innovation and comprehensive patient care solutions tailored specifically to the French medical landscape. Through these initiatives, LivaNova continues to enhance its reputation and competitiveness within the market. ### **Key Companies in the France Extracorporeal Membrane Oxygenation Machine Market Include** ## **France Extracorporeal Membrane Oxygenation Machine Market Industry Developments** Recent developments in the France Extracorporeal Membrane Oxygenation Machine Market are underscored by an increasing adoption of advanced technologies aimed at improving patient outcomes in critical care. Noteworthy is the growth in market valuation, spurred by investments in Research and Development by companies like Maquet and LivaNova, which are focusing on enhancing the functionality and efficiency of their product offerings. In the first quarter of 2023, Medtronic announced a partnership with French healthcare institutions to enhance training for healthcare professionals utilizing ECMO technology. Furthermore, in late 2022, Baxter International expanded its product portfolio in France through an acquisition, aiming to strengthen its market presence and capabilities in the life support systems segment. Notably, the surge in severe respiratory conditions during recent health crises has significantly impacted the demand for Extracorporeal Membrane Oxygenation Machines, prompting manufacturers like Terumo and Fresenius Kabi to ramp up production. This acceleration aligns with initiatives by the French government to bolster healthcare infrastructure and improve access to advanced medical technologies, reflecting the market's readiness for further innovation and expansion in the coming years. ## **France Extracorporeal Membrane Oxygenation Machine Market Segmentation Insights** ### **Extracorporeal Membrane Oxygenation Machine Market Application Outlook** ### **Extracorporeal Membrane Oxygenation Machine Market End User Outlook** ### **Extracorporeal Membrane Oxygenation Machine Market Product Type Outlook** ### **Extracorporeal Membrane Oxygenation Machine Market Component Outlook** ## Market Drivers ### Advancements in Medical Technology Technological innovations in the medical field are driving the growth of the extracorporeal membrane-oxygenation-machine market. Recent advancements in ECMO technology, such as miniaturization and enhanced biocompatibility, have made these machines more efficient and user-friendly. The introduction of portable ECMO systems allows for greater flexibility in patient management, particularly in emergency situations. Furthermore, the integration of artificial intelligence and data analytics into ECMO systems enhances monitoring capabilities, leading to improved patient outcomes. As hospitals in France increasingly adopt these advanced technologies, the demand for extracorporeal membrane-oxygenation machines is likely to rise. This trend suggests a shift towards more sophisticated and effective life support solutions in critical care settings. ### Government Initiatives and Funding Government initiatives aimed at enhancing critical care infrastructure are significantly impacting the extracorporeal membrane-oxygenation-machine market. In France, various funding programs and policies are being implemented to support the acquisition of advanced medical technologies, including ECMO machines. These initiatives are designed to improve healthcare delivery and ensure that hospitals are equipped to handle complex medical cases. The French government has allocated substantial budgets for healthcare improvements, which includes investments in ECMO technology. This financial support is likely to stimulate market growth, as healthcare facilities are encouraged to adopt state-of-the-art equipment. The combination of government backing and the need for advanced life support systems suggests a promising outlook for the extracorporeal membrane-oxygenation-machine market. ### Rising Awareness and Training Programs The growing awareness of extracorporeal membrane-oxygenation technology among healthcare professionals is a vital driver for the market. Training programs and workshops aimed at educating medical staff about ECMO procedures and benefits are becoming more prevalent in France. These initiatives are often supported by healthcare institutions and professional organizations, emphasizing the importance of proper training in the effective use of ECMO machines. As more healthcare providers recognize the potential of ECMO in saving lives, the demand for these machines is expected to increase. This heightened awareness, coupled with ongoing education, indicates a positive trajectory for the extracorporeal membrane-oxygenation-machine market, as skilled professionals are essential for the successful implementation of this technology. ### Increasing Incidence of Respiratory Diseases The rising prevalence of respiratory diseases in France is a crucial driver for the extracorporeal membrane-oxygenation-machine market. Conditions such as chronic obstructive pulmonary disease (COPD) and pneumonia necessitate advanced respiratory support systems. According to health statistics, respiratory diseases account for a significant portion of hospital admissions, leading to an increased demand for extracorporeal membrane oxygenation (ECMO) machines. The healthcare system's focus on improving patient outcomes and reducing mortality rates further propels the need for these machines. As hospitals and healthcare facilities strive to enhance their critical care capabilities, investments in ECMO technology are likely to rise, thereby expanding the market. This trend indicates a growing recognition of the importance of advanced life support systems in managing severe respiratory conditions. ### Aging Population and Increased Healthcare Expenditure France's aging population is a significant factor influencing the extracorporeal membrane-oxygenation-machine market. As the demographic shifts towards an older age group, the incidence of age-related health issues, including heart and lung diseases, is expected to rise. This demographic change is accompanied by increased healthcare expenditure, as the government and private sectors allocate more resources to advanced medical technologies. Reports suggest that healthcare spending in France is projected to grow by approximately 3.5% annually, creating a favorable environment for the adoption of ECMO machines. The combination of an aging population and rising healthcare budgets indicates a robust market potential for extracorporeal membrane-oxygenation machines, as healthcare providers seek to improve patient care and outcomes. ## Future Outlook The Extracorporeal Membrane Oxygenation Machine Market extracorporeal membrane-oxygenation-machine market is projected to grow at a 5.74% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands. **New opportunities:** - Development of portable ECMO systems for emergency medical services. Expansion of telemedicine integration for remote monitoring solutions. Partnerships with hospitals for ECMO training and certification programs. By 2035, the market is expected to achieve substantial growth, reflecting enhanced healthcare capabilities. ## Segment Insights ### By Application: Cardiac Support (Largest) vs. Respiratory Support (Fastest-Growing) In the France extracorporeal membrane-oxygenation-machine market, the distribution of market share among the application segments reveals that Cardiac Support holds the largest share. This segment is critical due to the high prevalence of cardiac diseases and the increasing number of surgeries requiring cardiac assistance. In contrast, the Respiratory Support segment, although smaller in share, is rapidly gaining traction as innovations and improvements in technology emerge, catering to a growing patient base requiring respiratory assistance. The growth trends in the application segment indicate a robust expansion, driven primarily by technological advancements and an increasing understanding of ECMO therapies in clinical settings. Furthermore, the need for effective respiratory support amid rising respiratory diseases has made this segment the fastest-growing. Hospitals are increasingly investing in ECMO machines to enhance patient care, reflecting a shift towards more advanced medical technologies in addressing critical health conditions. Cardiac Support (Dominant) vs. Respiratory Support (Emerging) The Cardiac Support segment significantly dominates the France extracorporeal membrane-oxygenation-machine market due to its established utilization in critical cardiac procedures. Known for its reliability and effectiveness, this segment is a staple in intensive care units, reflecting the high demand from health facilities. Conversely, the Respiratory Support segment is emerging with great potential, influenced by an increase in respiratory ailments and a greater focus on improving patient outcomes. Although it is still developing, advancements in technology and training for healthcare professionals are boosting its market presence, making it an important area of growth. The interplay of these two segments highlights the evolving nature of healthcare needs and the importance of ECMO systems in modern medicine. ### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the France extracorporeal membrane-oxygenation-machine market, hospitals hold the largest market share, significantly surpassing other segments. This dominance is attributed to the high demand for advanced medical equipment in critical care units and the increasing number of patients requiring ECMO support for respiratory and cardiac conditions. On the other hand, ambulatory surgical centers are emerging as the fastest-growing segment, benefitting from advancements in medical technologies and a growing preference for outpatient procedures. The shift towards minimally invasive surgeries and the increasing focus on reducing hospital stay durations are key drivers propelling growth in this segment. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals are characterized by their established infrastructure, comprehensive service offerings, and access to a larger patient demographic, making them the dominant end user in the France extracorporeal membrane-oxygenation-machine market. They typically invest significantly in advanced technology to enhance patient outcomes. In contrast, ambulatory surgical centers are becoming increasingly relevant with their focus on convenience and efficiency in outpatient care. Their growth is fueled by rising healthcare costs and a changing healthcare landscape that encourages shortened hospital stays and faster recovery methodologies, establishing them as a vital emerging segment. ### By Product Type: Venoarterial ECMO (Largest) vs. Venovenous ECMO (Fastest-Growing) In the France extracorporeal membrane-oxygenation-machine market, Venoarterial ECMO currently holds the largest market share, driven by its critical role in supporting patients with cardiac and respiratory failure. Venovenous ECMO, while smaller in market share, is rapidly gaining recognition due to its effectiveness in treating patients with severe respiratory issues needing temporary support. Growth trends indicate a significant rise in demand for Venovenous ECMO, fueled by advancements in technology and increased patient awareness. Continuous innovations and improved clinical outcomes from these machines have made them an essential part of critical care in hospitals, thereby driving their market presence in the region. Venoarterial ECMO (Dominant) vs. Venovenous ECMO (Emerging) Venoarterial ECMO serves as the dominant product type within the France extracorporeal membrane-oxygenation-machine market, primarily utilized in patients experiencing both cardiac and respiratory failure. Its broad applicability and established clinical protocols support its extensive use. Meanwhile, Venovenous ECMO is emerging as a vital alternative, particularly for patients with isolated respiratory failure, reflecting a shift towards less invasive methods. This growth is largely attributed to enhanced patient outcomes, ongoing research, and the development of new technologies that improve the efficiency and safety of ECMO procedures. As the medical community continues to recognize the benefits of these systems, both segments are expected to see evolving roles in critical care environments. ### By Component: Membrane Oxygenator (Largest) vs. Blood Pumps (Fastest-Growing) The France extracorporeal membrane-oxygenation-machine market exhibits a well-defined market share distribution amongst its key components. The Membrane Oxygenator holds a significant portion of the market, benefiting from its essential role in oxygen transfer during ECMO procedures. Following closely are Blood Pumps, which are gaining traction due to advancements in technology and their increasing adoption in clinical settings, alongside Heat Exchangers that, while vital, occupy a smaller share in comparison. Growth trends within this segment are primarily driven by the rising incidence of respiratory illnesses and the necessity for innovative treatment solutions. Blood Pumps are emerging as the fastest-growing component owing to their enhanced efficiency and the push for minimally invasive procedures. Meanwhile, the Membrane Oxygenator remains dominant, cementing its position with consistent advances in design and efficiency, thereby addressing a critical need in patient care. Technology: Membrane Oxygenator (Dominant) vs. Blood Pumps (Emerging) The Membrane Oxygenator is a dominant element in the France extracorporeal membrane-oxygenation-machine market, known for its critical function of facilitating gas exchange in patients undergoing ECMO. Its reliability and efficiency make it indispensable in the treatment of severe cardiac and respiratory failure. On the other hand, Blood Pumps are seen as an emerging segment driven by innovation and the demand for enhanced patient care. They offer improved flow rates and minimize hemolysis, catering to the growing emphasis on patient safety and comfort. Both segments are evolving, with Membrane Oxygenators sustaining their market leadership while Blood Pumps rapidly make strides through technological advancements and expanding application in various medical scenarios. ## Competitive Benchmarking The extracorporeal membrane-oxygenation-machine market in France is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include advancements in technology, increasing prevalence of respiratory and cardiac diseases, and a growing emphasis on patient-centric care. Major players such as Medtronic (US), Getinge (SE), and LivaNova (GB) are strategically positioned to leverage these trends. Medtronic (US) focuses on innovation through continuous product development, while Getinge (SE) emphasizes regional expansion and partnerships to enhance its market presence. LivaNova (GB) appears to be concentrating on digital transformation initiatives, which collectively shape a competitive environment that is increasingly reliant on technological advancements and strategic collaborations. In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of fluctuating global trade dynamics. The market structure is moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for niche players to thrive, while larger companies consolidate their positions through strategic acquisitions and partnerships, thereby enhancing their competitive edge. In October 2025, Medtronic (US) announced the launch of a new generation of its extracorporeal membrane oxygenation systems, which incorporate advanced AI algorithms for real-time patient monitoring. This strategic move is likely to enhance patient outcomes and streamline clinical workflows, positioning Medtronic (US) as a leader in innovation within the market. The integration of AI technology not only improves operational efficiency but also aligns with the growing trend towards personalized medicine. In September 2025, Getinge (SE) expanded its manufacturing capabilities in France by investing €20 million in a new facility dedicated to the production of extracorporeal membrane-oxygenation machines. This investment underscores Getinge's commitment to localizing production and enhancing supply chain resilience. By increasing its manufacturing footprint, Getinge (SE) aims to better serve the European market and respond swiftly to demand fluctuations, thereby solidifying its competitive position. In August 2025, LivaNova (GB) entered into a strategic partnership with a leading French hospital network to develop and implement a telemedicine platform for remote monitoring of patients using extracorporeal membrane-oxygenation machines. This collaboration is indicative of LivaNova's focus on digital transformation and reflects a broader trend towards integrating technology in patient care. Such initiatives not only enhance patient engagement but also improve clinical outcomes, thereby reinforcing LivaNova's market position. As of November 2025, current competitive trends are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are shaping the landscape, enabling companies to pool resources and expertise to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, reliability in supply chains, and enhanced patient care solutions. This shift suggests that companies that prioritize innovation and adaptability will be better positioned to thrive in the evolving market. ## Recent News & Developments Recent developments in the France Extracorporeal Membrane Oxygenation Machine Market are underscored by an increasing adoption of advanced technologies aimed at improving patient outcomes in critical care. Noteworthy is the growth in market valuation, spurred by investments in Research and Development by companies like Maquet and LivaNova, which are focusing on enhancing the functionality and efficiency of their product offerings. In the first quarter of 2023, Medtronic announced a partnership with French healthcare institutions to enhance training for healthcare professionals utilizing ECMO technology. Furthermore, in late 2022, Baxter International expanded its product portfolio in France through an acquisition, aiming to strengthen its market presence and capabilities in the life support systems segment. Notably, the surge in severe respiratory conditions during recent health crises has significantly impacted the demand for Extracorporeal Membrane Oxygenation Machines, prompting manufacturers like Terumo and Fresenius Kabi to ramp up production. This acceleration aligns with initiatives by the French government to bolster healthcare infrastructure and improve access to advanced medical technologies, reflecting the market's readiness for further innovation and expansion in the coming years. ## Report Scope | MARKET SIZE 2024 | 83.86(USD Million) | | --- | --- | | MARKET SIZE 2025 | 88.67(USD Million) | | MARKET SIZE 2035 | 154.99(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.74% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US) | | Segments Covered | Application, End User, Product Type, Component | | Key Market Opportunities | Advancements in technology and increasing demand for critical care solutions drive growth in the extracorporeal membrane-oxygenation-machine market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the extracorporeal membrane-oxygenation-machine market. | | Countries Covered | France | ## Frequently Asked Questions **Q: What is the projected market valuation for the France extracorporeal membrane-oxygenation-machine market in 2035?** A: The projected market valuation for 2035 is $154.99 Million. **Q: What was the overall market valuation in 2024?** A: The overall market valuation was $83.86 Million in 2024. **Q: What is the expected CAGR for the France extracorporeal membrane-oxygenation-machine market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 5.74%. **Q: Which application segment is expected to show the highest growth in the market?** A: The Cardiac Support application segment is expected to grow from $30.0 Million to $55.0 Million. **Q: What are the key players in the France extracorporeal membrane-oxygenation-machine market?** A: Key players include Medtronic, Getinge, LivaNova, Fresenius SE, Terumo Corporation, Maquet, Nipro Corporation, and Cleveland Medical Devices. **Q: How does the market for Venovenous ECMO compare to other product types?** A: The Venovenous ECMO product type is projected to grow from $35.0 Million to $65.0 Million, indicating strong demand. **Q: What is the expected market size for hospitals as an end user in 2035?** A: The expected market size for hospitals as an end user is projected to reach $90.0 Million by 2035. **Q: What is the valuation range for Blood Pumps in the component segment?** A: The valuation range for Blood Pumps in the component segment is from $25.0 Million to $45.0 Million. **Q: What is the anticipated growth for Home Care Settings in the end user segment?** A: Home Care Settings are expected to grow from $13.86 Million to $24.99 Million by 2035. **Q: Which component is projected to have the highest valuation in 2035?** A: The Membrane Oxygenator component is projected to have a valuation range of $30.0 Million to $55.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/france-extracorporeal-membrane-oxygenation-machine-market-50830*